Open an account

Aptorum Group

NIKI · NASDAQ

$1.83−$0.03 (−1.61%)TodayMarket closed ·
Prev close $1.86

About NIKI

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Employees
1
Headquarters
London
Listed
Dec 18, 2018
Sector
Health Care
Industry
Biotechnology
Website
aptorumgroup.com

NIKI key statistics

Market cap
5.71M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
18.13K
Volume
5.15K
Open price
$1.80
High today
$1.94
Low today
$1.81
52 Week high
$17.20
52 Week low
$1.81

Aptorum Group (NIKI) at a glance

Aptorum Group (NIKI) last traded at $1.83, with a market cap of 5.71M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.81 and $1.94. The current price is 1.1% above the day's low and 5.7% below its high.

Volume so far is 5.15K shares, below the average of 18.13K shares a day.

Over the past year Aptorum Group has ranged from $1.81 to $17.20, and now sits 0% of the way up that range.

NIKI news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

Similar companies

Companies in the same industry as Aptorum Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.